blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1546734

EP1546734 - N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.09.2016
Database last updated on 06.11.2024
Most recent event   Tooltip16.09.2016No opposition filed within time limitpublished on 19.10.2016  [2016/42]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2015/46]
Former [2005/26]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / MERCKEN, Marc, Hubert
Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340 Beerse / BE
02 / VANDERMEEREN, Marc, Maria, Pierre, Pelagie
Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340 Beerse / BE
 [2015/46]
Former [2005/26]01 / MERCKEN, Marc Hubert, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340 Beerse / BE
02 / VANDERMEEREN, Marc M.P.P, Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date03798156.009.09.2003
[2005/26]
WO2003EP10092
Priority number, dateWO2002EP1106227.09.2002         Original published format: PCT/EP0211/062
[2005/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004029630
Date:08.04.2004
Language:EN
[2004/15]
Type: A1 Application with search report 
No.:EP1546734
Date:29.06.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 08.04.2004 takes the place of the publication of the European patent application.
[2005/26]
Type: B1 Patent specification 
No.:EP1546734
Date:11.11.2015
Language:EN
[2015/46]
Search report(s)International search report - published on:EP08.04.2004
ClassificationIPC:G01N33/68, C12N5/20, C07K16/18
[2005/26]
CPC:
G01N33/6896 (EP,US); A61P25/28 (EP); A61P9/00 (EP);
C07K16/18 (EP,US); C07K2317/34 (US); G01N2333/4709 (EP,US);
G01N2800/2821 (EP,US); G01N2800/52 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2015/46]
Former [2005/26]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL27.04.2005
LT27.04.2005
LV27.04.2005
MK27.04.2005
TitleGerman:MONOKLONALE ANTIKÖRPER GEGEN IN N-11 VERKÜRZTES BETA-AMYLOID, ZUSAMMENSETZUNGEN,VERFAHREN UND VERWENDUNGEN[2015/26]
English:N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES[2005/26]
French:ANTICORPS MONOCLONAUX TRONQUES RECONNAISSANT LES PEPTIDES BETA-AMYLOIDES N-11, COMPOSITIONS, PROCEDES ET APPLICATIONS[2005/26]
Former [2005/26]MONOKONOALE ANTIKÖRPER GEGEN IN N-11 VERKÜRZTES BETA-AMYLOID, ZUSAMMENSETZUNGEN,VERFAHREN UND VERWENDUNGEN
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase27.04.2005National basic fee paid 
27.04.2005Designation fee(s) paid 
27.04.2005Examination fee paid 
Examination procedure25.03.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.04.2005Examination requested  [2005/26]
26.02.2007Despatch of a communication from the examining division (Time limit: M06)
27.08.2007Reply to a communication from the examining division
18.05.2009Despatch of a communication from the examining division (Time limit: M06)
23.10.2009Reply to a communication from the examining division
13.04.2011Despatch of a communication from the examining division (Time limit: M06)
24.10.2011Reply to a communication from the examining division
19.06.2013Despatch of a communication from the examining division (Time limit: M04)
03.10.2013Reply to a communication from the examining division
30.04.2015Cancellation of oral proceeding that was planned for 19.05.2015
19.05.2015Date of oral proceedings (cancelled)
29.05.2015Communication of intention to grant the patent
11.09.2015Fee for grant paid
11.09.2015Fee for publishing/printing paid
11.09.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.02.2007
Opposition(s)12.08.2016No opposition filed within time limit [2016/42]
Fees paidRenewal fee
30.09.2005Renewal fee patent year 03
02.10.2006Renewal fee patent year 04
01.10.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
30.09.2009Renewal fee patent year 07
30.09.2010Renewal fee patent year 08
30.09.2011Renewal fee patent year 09
01.10.2012Renewal fee patent year 10
30.09.2013Renewal fee patent year 11
30.09.2014Renewal fee patent year 12
30.09.2015Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0162801  (UNIV WASHINGTON [US], et al) [A] 1-16 * the whole document *
 [X]  - SAITO TAKANOMI C ET AL, "Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.", NEUROSCIENCE LETTERS, (1996), vol. 215, no. 3, ISSN 0304-3940, pages 173 - 176, XP002236342 [X] 1-16 * page 173 *

DOI:   http://dx.doi.org/10.1016/0304-3940(96)12970-0
 [DA]  - NASLUND JAN ET AL, "Relative abundance of Alzheimer A-beta amyloid peptide variants in Alzheimer disease and normal aging.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, 1994, (1994), vol. 91, no. 18, ISSN 0027-8424, pages 8378 - 8382, XP002236343 [DA] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.91.18.8378
 [A]  - VASSAR R ET AL, "BETA-SECRETASE CLEAVAGE OF ALZHEIMER'S AMYLOID PRECURSOR PROTEIN BYTHE TRANSMEMBRANE ASPARTIC PROTEASE BACE", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, (1999), vol. 286, no. 5440, ISSN 0036-8075, pages 735 - 741, XP000914811 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.286.5440.735
Examination   - ASAMI-ODAKA A ET AL, "Long amyloid Beta-protein secreted from wild-type human neurblastoma IMR-32 cells", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19950101), vol. 34, no. 32, doi:10.1021/BI00032A022, ISSN 0006-2960, pages 10272 - 10278, XP002973741

DOI:   http://dx.doi.org/10.1021/bi00032a022
    - MORT J S ET AL, "The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways", MP. MOLECULAR PATHOLOGY, BMJ PUBLISHING GROUP, LONDON, GB, (19990201), vol. 52, no. 1, ISSN 1366-8714, pages 11 - 18, XP002670376

DOI:   http://dx.doi.org/10.1136/mp.52.1.11
    - IDA ET AL, "Analysis of heterogeneous ssA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19960913), vol. 271, no. 37, doi:10.1074/JBC.271.37.22908, ISSN 0021-9258, pages 22908 - 22914, XP002138701

DOI:   http://dx.doi.org/10.1074/jbc.271.37.22908
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.